1. Home
  2. VIR vs RBBN Comparison

VIR vs RBBN Comparison

Compare VIR & RBBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • RBBN
  • Stock Information
  • Founded
  • VIR 2016
  • RBBN 1997
  • Country
  • VIR United States
  • RBBN United States
  • Employees
  • VIR N/A
  • RBBN N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • RBBN EDP Services
  • Sector
  • VIR Health Care
  • RBBN Technology
  • Exchange
  • VIR Nasdaq
  • RBBN Nasdaq
  • Market Cap
  • VIR 706.4M
  • RBBN 671.1M
  • IPO Year
  • VIR 2019
  • RBBN 2000
  • Fundamental
  • Price
  • VIR $4.80
  • RBBN $3.85
  • Analyst Decision
  • VIR Strong Buy
  • RBBN Strong Buy
  • Analyst Count
  • VIR 11
  • RBBN 4
  • Target Price
  • VIR $25.73
  • RBBN $6.00
  • AVG Volume (30 Days)
  • VIR 1.5M
  • RBBN 590.4K
  • Earning Date
  • VIR 10-30-2025
  • RBBN 10-22-2025
  • Dividend Yield
  • VIR N/A
  • RBBN N/A
  • EPS Growth
  • VIR N/A
  • RBBN N/A
  • EPS
  • VIR N/A
  • RBBN N/A
  • Revenue
  • VIR $19,000,000.00
  • RBBN $863,459,000.00
  • Revenue This Year
  • VIR N/A
  • RBBN $7.26
  • Revenue Next Year
  • VIR $11.08
  • RBBN $5.52
  • P/E Ratio
  • VIR N/A
  • RBBN N/A
  • Revenue Growth
  • VIR N/A
  • RBBN 7.68
  • 52 Week Low
  • VIR $4.16
  • RBBN $2.91
  • 52 Week High
  • VIR $14.45
  • RBBN $5.38
  • Technical
  • Relative Strength Index (RSI)
  • VIR 46.19
  • RBBN 45.77
  • Support Level
  • VIR $4.75
  • RBBN $3.79
  • Resistance Level
  • VIR $5.39
  • RBBN $4.14
  • Average True Range (ATR)
  • VIR 0.30
  • RBBN 0.14
  • MACD
  • VIR -0.02
  • RBBN -0.02
  • Stochastic Oscillator
  • VIR 5.63
  • RBBN 13.33

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.

Share on Social Networks: